855 related articles for article (PubMed ID: 12384919)
1. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
2. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
3. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
[TBL] [Abstract][Full Text] [Related]
4. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
Rousseau JC; Chevrel G; Schott AM; Garnero P
Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides.
Christensen AF; Hørslev-Petersen K; Christgau S; Lindegaard HM; Lottenburger T; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Heegaard NH; Vestergaard A; Jurik AG; Ostergaard M; Junker P
J Rheumatol; 2010 Jun; 37(6):1113-20. PubMed ID: 20436079
[TBL] [Abstract][Full Text] [Related]
6. Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure.
Berry PA; Maciewicz RA; Wluka AE; Downey-Jones MD; Forbes A; Hellawell CJ; Cicuttini FM
Ann Rheum Dis; 2010 Oct; 69(10):1816-22. PubMed ID: 20551154
[TBL] [Abstract][Full Text] [Related]
7. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.
Sharif M; Kirwan J; Charni N; Sandell LJ; Whittles C; Garnero P
Rheumatology (Oxford); 2007 Jun; 46(6):938-43. PubMed ID: 17387119
[TBL] [Abstract][Full Text] [Related]
8. Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis.
Berry PA; Jones SW; Cicuttini FM; Wluka AE; Maciewicz RA
Arthritis Rheum; 2011 Mar; 63(3):700-7. PubMed ID: 21305502
[TBL] [Abstract][Full Text] [Related]
9. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
[TBL] [Abstract][Full Text] [Related]
10. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
Cibere J; Thorne A; Kopec JA; Singer J; Canvin J; Robinson DB; Pope J; Hong P; Grant E; Lobanok T; Ionescu M; Poole AR; Esdaile JM
J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.
Garnero P; Peterfy C; Zaim S; Schoenharting M
Arthritis Rheum; 2005 Sep; 52(9):2822-9. PubMed ID: 16145678
[TBL] [Abstract][Full Text] [Related]
12. Type II collagen peptides for measuring cartilage degradation.
Henrotin Y; Deberg M; Dubuc JE; Quettier E; Christgau S; Reginster JY
Biorheology; 2004; 41(3-4):543-7. PubMed ID: 15299285
[TBL] [Abstract][Full Text] [Related]
13. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
14. Validation of American College of Rheumatology classification criteria for knee osteoarthritis using arthroscopically defined cartilage damage scores.
Wu CW; Morrell MR; Heinze E; Concoff AL; Wollaston SJ; Arnold EL; Singh R; Charles C; Skovrun ML; FitzGerald JD; Moreland LW; Kalunian KC
Semin Arthritis Rheum; 2005 Dec; 35(3):197-201. PubMed ID: 16325660
[TBL] [Abstract][Full Text] [Related]
15. Does hand osteoarthritis predict future hip or knee osteoarthritis?
Dahaghin S; Bierma-Zeinstra SM; Reijman M; Pols HA; Hazes JM; Koes BW
Arthritis Rheum; 2005 Nov; 52(11):3520-7. PubMed ID: 16255023
[TBL] [Abstract][Full Text] [Related]
16. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis.
Jung M; Christgau S; Lukoschek M; Henriksen D; Richter W
Pathobiology; 2004; 71(2):70-6. PubMed ID: 14707441
[TBL] [Abstract][Full Text] [Related]
17. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study.
Henrotin Y; Bannuru R; Malaise M; Ea HK; Confavreux C; Bentin J; Urbin-Choffray D; Conrozier T; Brasseur JP; Thomas P; Hick AC; Marinello A; Giordan N; Richette P
BMC Musculoskelet Disord; 2019 Jun; 20(1):293. PubMed ID: 31215422
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis.
Rousseau JC; Zhu Y; Miossec P; Vignon E; Sandell LJ; Garnero P; Delmas PD
Osteoarthritis Cartilage; 2004 Jun; 12(6):440-7. PubMed ID: 15135140
[TBL] [Abstract][Full Text] [Related]
20. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis.
Lohmander LS; Yoshihara Y; Roos H; Kobayashi T; Yamada H; Shinmei M
J Rheumatol; 1996 Oct; 23(10):1765-9. PubMed ID: 8895155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
